Dynamic Simulations of Pathways Downstream of ERBB-Family: Exploration of Parameter Space and Effects of Its Variation on Network Behavior

The signaling-network immediately downstream of the ErbB-family is very important in BC and other cancers, especially considering treatment of the excess of function of dominant onco-proteins with oncoprotein inhibitors. We studied and implemented dynamic simulations of four downstream pathways. The fragment of the signaling-network we evaluated was described as a Molecular Interaction Map. Our simulations involved 242 modified species and complexes, 279 reversible reactions, 110 catalytic activities. We used Ordinary Differential Equations for our simulations. We started an analysis of sensitivity / robustness of our network, and we systematically introduced fluctuations of total concentrations of independent molecular species. We adopted mostly the strategy of a random sampling of 1000 cases for each instance of increasing numbers of perturbations. Only a small minority of cases showed an important sensitivity, the number of sensitive cases increased moderately for increasing numbers of perturbations. In most cases the effect of introducing virtual mutations and virtual onco-protein inhibitors was more important than the effect of randomly introduced perturbations, this suggests an acceptable robustness of our network. The importance of our work is primarily related to the fact that the complexity of the 39 basic species signaling-network region we analyzed is of difficult intuitive understanding for a "naked" human mind. Dynamic network simulations appear to be an useful support for an "a posteriori" mental comprehension by a cancer researcher of the behavior of a network of this degree of complexity. The present report suggests the feasibility of a computational approach even in the presence of a multiple number of uncertainties about parameter values.

[1]  C. Downes,et al.  PTEN function: how normal cells control it and tumour cells lose it. , 2004, The Biochemical journal.

[2]  B. Kholodenko,et al.  Ligand-dependent responses of the ErbB signaling network: experimental and modeling analyses , 2007, Molecular systems biology.

[3]  G. Parmigiani,et al.  A multidimensional analysis of genes mutated in breast and colorectal cancers. , 2007, Genome research.

[4]  D. Lauffenburger,et al.  Input–output behavior of ErbB signaling pathways as revealed by a mass action model trained against dynamic data , 2009, Molecular systems biology.

[5]  S. Orsulic,et al.  E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation. , 1999, Journal of cell science.

[6]  H V Westerhoff,et al.  Why cytoplasmic signalling proteins should be recruited to cell membranes. , 2000, Trends in cell biology.

[7]  J. Weinstein,et al.  Depicting combinatorial complexity with the molecular interaction map notation , 2006, Molecular systems biology.

[8]  Uri Alon,et al.  An Introduction to Systems Biology , 2006 .

[9]  S Parodi,et al.  Dynamic simulations of pathways downstream of ERBB-family, including mutations and treatments: concordance with experimental results. , 2010, Current cancer drug targets.

[10]  J. Tyson,et al.  Chemical kinetic theory: understanding cell-cycle regulation. , 1996, Trends in biochemical sciences.

[11]  Raffaele Pesenti,et al.  Simulations of the EGFR - KRAS - MAPK Signalling Network in Colon Cancer. Virtual Mutations and Virtual Treatments with Inhibitors Have More Important Effects Than a 10 Times Range of Normal Parameters and Rates Fluctuations , 2009, CIBB.

[12]  G. Hampton,et al.  A phosphoproteomic analysis of the ErbB2 receptor tyrosine kinase signaling pathways. , 2006, Biochemistry.

[13]  A. Barabasi,et al.  Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.

[14]  Boris N Kholodenko,et al.  Scaffolding Protein Grb2-associated Binder 1 Sustains Epidermal Growth Factor-induced Mitogenic and Survival Signaling by Multiple Positive Feedback Loops* , 2006, Journal of Biological Chemistry.

[15]  D. Lauffenburger,et al.  Physicochemical modelling of cell signalling pathways , 2006, Nature Cell Biology.

[16]  G. Parmigiani,et al.  Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.

[17]  B. Kholodenko,et al.  Quantification of Short Term Signaling by the Epidermal Growth Factor Receptor* , 1999, The Journal of Biological Chemistry.

[18]  Igor Goryanin,et al.  The impact of the regulatory design on the response of epidermal growth factor receptor‐mediated signal transduction towards oncogenic mutations , 2007, The FEBS journal.

[19]  B N Kholodenko,et al.  Signal processing at the Ras circuit: what shapes Ras activation patterns? , 2004, Systems biology.